Cover Image
市場調查報告書

ProCertus BioPharm Inc. - 產品平台分析

ProCertus BioPharm Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 309670
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
ProCertus BioPharm Inc. - 產品平台分析 ProCertus BioPharm Inc. - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 21 Pages
簡介

ProCertus BioPharm Inc. 正在開發、銷售為了防止癌症治療造成之副作用的醫藥品。該公司產品有守住因化療及頭部放射線治療的癌症及骨髓移植患者之毛囊幹細胞以防止掉髮,還有守住放射線治療下的皮膚幹細胞,保護口腔、咽喉的黏膜不受黏膜炎侵害。

本報告提供ProCertus BioPharm Inc.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

ProCertus BioPharm Inc.的基本資料

ProCertus BioPharm Inc.概要

  • 主要資訊
  • 企業資料

ProCertus BioPharm Inc.:R&D概要

  • 主要的治療範圍

ProCertus BioPharm Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

ProCertus BioPharm Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

ProCertus BioPharm Inc.:藥物簡介

  • ProDermaCel
  • OralX
  • PrC-210

ProCertus BioPharm Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

ProCertus BioPharm Inc.:暫停中的計劃

ProCertus BioPharm Inc.:總公司和子公司的所在地

附錄

圖表一覽

目錄
Product Code: GMDHC05795CDB

Summary

Global Markets Direct's, 'ProCertus BioPharm Inc. - Product Pipeline Review - 2014', provides an overview of the ProCertus BioPharm Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ProCertus BioPharm Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ProCertus BioPharm Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ProCertus BioPharm Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ProCertus BioPharm Inc.'s pipeline products

Reasons to buy

  • Evaluate ProCertus BioPharm Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ProCertus BioPharm Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ProCertus BioPharm Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ProCertus BioPharm Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ProCertus BioPharm Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ProCertus BioPharm Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ProCertus BioPharm Inc. Snapshot
    • ProCertus BioPharm Inc. Overview
    • Key Information
    • Key Facts
  • ProCertus BioPharm Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • ProCertus BioPharm Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ProCertus BioPharm Inc. - Pipeline Products Glance
    • ProCertus BioPharm Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • ProCertus BioPharm Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • ProCertus BioPharm Inc. - Drug Profiles
    • ProDermaCel
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OralX
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PrC-210
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ProCertus BioPharm Inc. - Pipeline Analysis
    • ProCertus BioPharm Inc. - Pipeline Products by Target
    • ProCertus BioPharm Inc. - Pipeline Products by Route of Administration
    • ProCertus BioPharm Inc. - Pipeline Products by Molecule Type
    • ProCertus BioPharm Inc. - Pipeline Products by Mechanism of Action
  • ProCertus BioPharm Inc. - Dormant Projects
  • ProCertus BioPharm Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ProCertus BioPharm Inc., Key Information
  • ProCertus BioPharm Inc., Key Facts
  • ProCertus BioPharm Inc. - Pipeline by Indication, 2014
  • ProCertus BioPharm Inc. - Pipeline by Stage of Development, 2014
  • ProCertus BioPharm Inc. - Monotherapy Products in Pipeline, 2014
  • ProCertus BioPharm Inc. - Phase I, 2014
  • ProCertus BioPharm Inc. - Preclinical, 2014
  • ProCertus BioPharm Inc. - Pipeline by Target, 2014
  • ProCertus BioPharm Inc. - Pipeline by Route of Administration, 2014
  • ProCertus BioPharm Inc. - Pipeline by Molecule Type, 2014
  • ProCertus BioPharm Inc. - Pipeline Products by Mechanism of Action, 2014
  • ProCertus BioPharm Inc. - Dormant Developmental Projects,2014

List of Figures

  • ProCertus BioPharm Inc. - Pipeline by Top 10 Indication, 2014
  • ProCertus BioPharm Inc. - Pipeline by Stage of Development, 2014
  • ProCertus BioPharm Inc. - Monotherapy Products in Pipeline, 2014
  • ProCertus BioPharm Inc. - Pipeline by Top 10 Route of Administration, 2014
Back to Top